tradingkey.logo

Niagen Bioscience Inc

NAGE
6.510USD
-0.200-2.98%
收盤 12/23, 16:00美東報價延遲15分鐘
518.45M總市值
24.82本益比TTM

Niagen Bioscience Inc

6.510
-0.200-2.98%

關於 Niagen Bioscience Inc 公司

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Niagen Bioscience Inc簡介

公司代碼NAGE
公司名稱Niagen Bioscience Inc
上市日期Jun 25, 2007
CEOFried (Robert N)
員工數量104
證券類型Ordinary Share
年結日Jun 25
公司地址10900 Wilshire Blvd Suite 600
城市LOS ANGELES
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編90024
電話13103886706
網址https://www.niagenbioscience.com/
公司代碼NAGE
上市日期Jun 25, 2007
CEOFried (Robert N)

Niagen Bioscience Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
1.65M
+4.22%
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
7.37K
+153.59%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Ben Shamsian
Mr. Ben Shamsian
Investor Relations
Investor Relations
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--
Mr. Gary Ng
Mr. Gary Ng
Independent Director
Independent Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--
Ms. Kristin Patrick
Ms. Kristin Patrick
Independent Director
Independent Director
--
--
Mr. Hamed Shahbazi
Mr. Hamed Shahbazi
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
1.65M
+4.22%
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
7.37K
+153.59%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Ben Shamsian
Mr. Ben Shamsian
Investor Relations
Investor Relations
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Brilliant Dynasty Ltd
14.30%
Pioneer Step Holdings, Ltd.
8.67%
The Vanguard Group, Inc.
5.02%
Nestle Health Science US Holdings, Inc.
4.78%
BlackRock Institutional Trust Company, N.A.
4.37%
其他
62.86%
持股股東
持股股東
佔比
Brilliant Dynasty Ltd
14.30%
Pioneer Step Holdings, Ltd.
8.67%
The Vanguard Group, Inc.
5.02%
Nestle Health Science US Holdings, Inc.
4.78%
BlackRock Institutional Trust Company, N.A.
4.37%
其他
62.86%
股東類型
持股股東
佔比
Corporation
31.56%
Investment Advisor
19.17%
Investment Advisor/Hedge Fund
13.94%
Hedge Fund
5.70%
Individual Investor
2.44%
Research Firm
1.42%
Pension Fund
0.68%
Bank and Trust
0.23%
Venture Capital
0.07%
其他
24.79%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
277
29.97M
37.55%
+806.79K
2025Q2
256
54.09M
67.83%
+1.52M
2025Q1
248
52.79M
67.45%
+991.43K
2024Q4
227
50.32M
64.79%
+3.69M
2024Q3
187
45.29M
58.88%
-2.22M
2024Q2
176
44.12M
58.29%
+362.19K
2024Q1
173
40.79M
55.40%
+2.41M
2023Q4
177
39.03M
53.11%
+1.29M
2023Q3
191
38.74M
52.74%
+56.61K
2023Q2
203
38.69M
53.76%
+732.31K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Brilliant Dynasty Ltd
11.41M
14.31%
+11.41M
--
Aug 20, 2024
Pioneer Step Holdings, Ltd.
6.92M
8.67%
--
--
Aug 20, 2024
The Vanguard Group, Inc.
3.92M
4.92%
+383.90K
+10.84%
Jun 30, 2025
Nestle Health Science US Holdings, Inc.
3.82M
4.79%
--
--
Apr 25, 2025
BlackRock Institutional Trust Company, N.A.
3.44M
4.31%
+105.31K
+3.16%
Jun 30, 2025
Black Sheep, FLP
2.08M
2.6%
--
--
Apr 25, 2025
Tieton Capital Management, LLC
1.58M
1.98%
-404.73K
-20.38%
Jun 30, 2025
Fried (Robert N)
1.65M
2.06%
+66.67K
+4.22%
Apr 25, 2025
Arrowstreet Capital, Limited Partnership
1.12M
1.4%
+129.51K
+13.08%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.30M
1.62%
+116.27K
+9.86%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
AdvisorShares Insider Advantage ETF
0.98%
Gabelli Love Our Planet & People ETF
0.27%
ALPS Barron's 400 ETF
0.2%
Even Herd Long Short ETF
0.11%
Principal U.S. Small-Cap ETF
0.08%
iShares Micro-Cap ETF
0.08%
Vanguard US Quality Factor ETF
0.07%
Vanguard US Momentum Factor ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Quality Growth Fund
0.06%
查看更多
AdvisorShares Insider Advantage ETF
佔比0.98%
Gabelli Love Our Planet & People ETF
佔比0.27%
ALPS Barron's 400 ETF
佔比0.2%
Even Herd Long Short ETF
佔比0.11%
Principal U.S. Small-Cap ETF
佔比0.08%
iShares Micro-Cap ETF
佔比0.08%
Vanguard US Quality Factor ETF
佔比0.07%
Vanguard US Momentum Factor ETF
佔比0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.06%
WisdomTree US SmallCap Quality Growth Fund
佔比0.06%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Niagen Bioscience Inc的前五大股東是誰?

Niagen Bioscience Inc的前五大股東如下:
Brilliant Dynasty Ltd
持有股份:11.41M
佔總股份比例:14.31%。
Pioneer Step Holdings, Ltd.
持有股份:6.92M
佔總股份比例:8.67%。
The Vanguard Group, Inc.
持有股份:3.92M
佔總股份比例:4.92%。
Nestle Health Science US Holdings, Inc.
持有股份:3.82M
佔總股份比例:4.79%。
BlackRock Institutional Trust Company, N.A.
持有股份:3.44M
佔總股份比例:4.31%。

Niagen Bioscience Inc的前三大股東類型是什麼?

Niagen Bioscience Inc 的前三大股東類型分別是:
Brilliant Dynasty Ltd
Pioneer Step Holdings, Ltd.
The Vanguard Group, Inc.

有多少機構持有Niagen Bioscience Inc(NAGE)的股份?

截至2025Q3,共有277家機構持有Niagen Bioscience Inc的股份,合計持有的股份價值約為29.97M,占公司總股份的37.55% 。與2025Q2相比,機構持股有所增加,增幅為-30.28%。

哪個業務部門對Niagen Bioscience Inc的收入貢獻最大?

在--,--業務部門對Niagen Bioscience Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI